+91 9891296838 / 9811747774
For adults and children with solid tumors, NTRK fusion (NTRK1, NTRK2, or NTRK3 fusion) is required. Larotrectinib is a broad-spectrum anticancer drug that is effective against many different tumors.Effective treatment types: lung cancer, thyroid cancer, melanoma, gastrointestinal cancer, colon cancer, soft tissue sarcoma, salivary gland, baby fibrosarcoma, appendiceal cancer, breast cancer, cholangiocarcinoma, pancreatic cancer and 17 other tumors.
IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.
For procurement cost of Laronib (Larotrectinib) brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the Laronib Larotrectinib medicine cost price in India.
The order for Laronib (Larotrectinib) will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Larotrectinib is used to treat certain tumors that are caused by an abnormal "NTRK" gene. Larotrectinib is used when the cancer has spread to other parts of the body or cannot be removed with surgery or other cancer treatments. It works by slowing or stopping the growth of cancer cells.
Laronib (Larotrectinib) Capsules
Generic Name: Larotrectinib
60/4 1st Floor, T&T Building, Indian Oil Complex,
Yusuf Sarai, New Delhi, Delhi 110016
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398
IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Laronib (Larotrectinib) on prescription and Import License in Patient's Name only.
For overseas patients, Laronib (Larotrectinib) can be made available in Send your enquiry to find Laronib (Larotrectinib) in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.
For Laronib (Larotrectinib) Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details
Larotrectinib Shows Durability and Tolerability in Expanded Analysis For More Details
Bayer gets EU CHMP nod for precision oncology treatment larotrectinib For More Details